葡萄糖依赖性促胰岛素多肽是人体胰腺多肽的促分泌素
研究探讨人GIP1-42是否刺激胰腺多肽(PP)分泌。在健康男性(n=10)和2型糖尿病(T2D)患者(n=12)中,静脉输注hGIP1-42在空腹血糖时增加PP浓度;高血糖钳夹期间,T2D患者PP反应显著,健康人无显著反应;胰岛素诱导低血糖期间,健康人PP反应显著,T2D患者无显著反应。离体猪胰腺灌注pGIP也增加PP输出。
要点
- GIP1-42在空腹血糖时增加健康人和T2D患者的血浆PP浓度。
- 高血糖钳夹时,GIP刺激PP分泌仅在T2D患者中显著,健康人反应被削弱。
- 胰岛素诱导低血糖期间,GIP刺激PP分泌仅在健康人中显著,T2D患者无显著反应。
核心结论
- GIP1-42增加健康人、T2D患者及离体猪胰腺的PP分泌。
- 高血糖削弱健康人中对hGIP1-42的PP反应,但T2D患者无此削弱。
研究设计与样本
- 研究分析两项在健康男性(n=10)和T2D患者(n=12)中进行的研究,静脉给予hGIP1-42,分别在空腹血糖、高血糖(12 mmol/L)和胰岛素诱导低血糖(目标:健康人2.5 mmol/L;T2D患者3.5 mmol/L)条件下测量血浆PP浓度。
- 离体猪胰腺(n=4)动脉内输注猪GIP1-42。
主要发现
- 健康人空腹血糖时,hGIP1-42 vs 盐水净iAUC[0-30min]为403 [116] vs -6 [57] pmol/L×min,P=0.004。
- T2D患者空腹血糖时,hGIP1-42 vs 盐水净iAUC[0-30min]为905 [177] vs -96 [86] pmol/L×min,P=0.009。
- T2D患者高血糖钳夹时,hGIP1-42 vs 盐水PP浓度为771 [160] vs -183 [117] pmol/L×min,P=0.001;健康人为-8 [86] vs -57 [53] pmol/L×min,P=0.69。
- 健康人胰岛素诱导血糖下降时,hGIP1-42 vs 盐水PP浓度为294 [88] vs -82 [53] pmol/L×min,P=0.0025;T2D患者为586 [314] vs -120 [53],P=0.070。
- 离体猪胰腺pGIP1-42增加PP输出(基线 vs 输注,24[5] vs 79 [16] pmol/min×min,P=0.044)。
临床怎么用
- GIP的促PP分泌作用受血糖水平调节,在健康人和T2D患者中存在差异。
- PP可能介导GIP对胃肠动力、食欲和血糖的调节,但需进一步验证。
局限性
- 研究样本量较小(健康人n=10,T2D患者n=12,离体猪胰腺n=4)。
- PP在GIP生理作用中的临床意义尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glucose-dependent insulinotropic polypeptide (GIP) has been suggested to stimulate the secretion of pancreatic polypeptide (PP), an islet hormone thought to regulate gut motility, appetite, and glycemia. OBJECTIVE: To determine whether human GIP1-42 (hGIP) stimulates PP secretion. METHOD: As glycemia modulates the secretion of PP, we measured plasma PP concentrations from 2 studies in healthy men (n = 10) and in patients with type 2 diabetes (T2D) (n = 12), where hGIP1-42 had been administered intravenously during fasting glycemia, hyperglycemia (12 mmol/L), and insulin-induced hypoglycemia (targets: 2.5 mmol/L [healthy]; 3.5 mmol/L [T2D]). Porcine GIP1-42 (pGIP) was also infused intra-arterially in isolated porcine pancreata (n = 4). RESULTS: Mean fasting plasma glucose concentrations were approximately 5 mmol/L (healthy) and approximately 8 mmol/L (T2D). At fasting glycemia, PP concentrations were higher during intravenous hGIP1-42 infusion compared with saline in healthy men (mean [standard error of the mean, SEM], net incremental areas under the curves (iAUCs)[0-30min], 403 [116] vs -6 [57] pmol/L × min; P = 0.004) and in patients with T2D (905 [177] vs -96 [86] pmol/L × min; P = 0.009). During hyperglycemic clamping, mean [SEM] PP concentrations were significantly higher during hGIP1-42 infusion compared with saline in patients with T2D (771 [160] vs -183 [117] pmol/L × min; P = 0.001), but not in healthy individuals (-8 [86] vs -57 [53] pmol/L × min; P = 0.69). When plasma glucose levels were declining in response to exogenous insulin, mean [SEM] PP concentrations were higher during hGIP1-42 infusion compared with saline in healthy individuals (294 [88] vs -82 [53] pmol/L × min; P = 0.0025), but not significantly higher in patients with T2D (586 [314] vs -120 [53]; P = 0.070). At target hypoglycemia, PP levels surged in both groups during both hGIP1-42 and saline infusions. In isolated pancreata, pGIP1-42 increased mean [SEM] PP output in the pancreatic venous effluent (baseline vs infusion, 24[5] vs 79 [16] pmol/min x min; P = 0.044). CONCLUSION: GIP1-42 increases plasma PP secretion in healthy individuals, patients with T2D, and isolated porcine pancreata. Hyperglycemia blunts the stimulatory effect of hGIP1-42 in healthy individuals, but not in patients with T2D.
引用
- Veedfald S, Vedtofte L, Skov-Jeppesen K, et al. Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans. J Clin Endocrinol Metab. 2020. PMID: 31665480. doi:10.1210/clinem/dgz097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。